JPRN-UMIN000009943
Completed
Phase 1
Vascular regeneration using autologous mesenchymal stem cells for peripheral arterial disease - Vascular regeneration using autologous mesenchymal stem cells for peripheral arterial disease
Rogenkai Welfare Group0 sites5 target enrollmentDecember 1, 2013
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Peripheral Arterial Disease (Fontaine stages three and four)
- Sponsor
- Rogenkai Welfare Group
- Enrollment
- 5
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)The patient of hepatitis B (HBV), hepatitis C (HCV), human immunodeficiency virus (HIV) infection, and adult T\-cell leukemia (2\)The hypersensitivity to a cow or pig origin protein, the patient that has the past of side effects (3\)The patient showing severe cardiac failure evidenced by cardiac echo examination. (4\)Malignant diseases. (5\)High\-risk retinopathy (6\)Serious problems of liver and renal function (7\)Interstitial pneumonia. (8\)Blood diseases such as anemia and leykocytosis. (9\)A pregnant woman, a nursing mother, the patient that may have become pregnant, the female patient who is planning pregnancy by the end of this treatment term. (10\)In addition, the patient whom the principal investigator or the researcher judged to be unsuitable based on the medical rationale
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Vascular regeneration therapy using autologous peripheral blood mononuclear cells for refractory skin ulcer associated with connective tissue diseases and vasculitisPatients with refractory skin ulcers resistant to normal treatment, mainly caused by connective tissue diseases and vasculitisJPRN-UMIN000024255Kumamoto University10
Completed
Not Applicable
Therapeutic Angiogenesis using Autologous Bone-Marrow Mononuclear Cells ImplantatioCLI(Critical limb ischemia) (ASO, Buerger disease, Collagen disease)JPRN-UMIN000023282Kyoto Prefectural University School of Medicine120
Active, not recruiting
Phase 1
Mesenchymal stem cells as treatment for non healing wounds on the fingers in patients with systemic sclerosissystemic sclerosisMedDRA version: 18.0Level: PTClassification code 10042953Term: Systemic sclerosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2015-000168-32-NLniversity Medical Center Utrecht
Recruiting
Phase 2
Mesenchymal stem cells for angiogenesis and neovascularisation in digital ulcers of systemic sclerosissclerodermaSystemic scleroderma10003816NL-OMON47582niversitair Medisch Centrum Utrecht20
Not yet recruiting
Not Applicable
Therapeutic angiogenesis using autologous bone marrow mononuclear cells implantation for Buerger diseaseCLI(Critical limb ischemia) (Buerger disease)JPRN-UMIN000027383Kyoto Prefectural University School of Medicine25